GlassScriptPhysician profile
Edward A Buro
NPI 1578566402
$1,598.02
in general payments reported to CMS, 2019-2025
16 companies · $54.52 in 2025
The $54.52 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $173 · 2021: $432 · 2022: $215 · 2023: $292 · 2024: $245 · 2025: $54.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $464.17 | 2020-2025 | Jublia |
| Paratek Pharmaceuticals, INC. | $302.93 | 2020-2024 | Nuzyra |
| Sebela Pharmaceuticals INC. | $155.59 | 2019-2023 | Pramosone, Naftin |
| Tactile Systems Technology INC | $126.27 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Organogenesis INC. | $108.15 | 2023 | Puraply |
| Djo, LLC | $84.47 | 2024 | Cmf |
| Merck Sharp & Dohme LLC | $55.96 | 2019 | |
| Smith+Nephew, INC. | $52.78 | 2019-2023 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $46.09 | 2019 | |
| Nabriva Therapeutics, Plc | $44.95 | 2020-2021 | |
| Boston Scientific Corporation | $34.93 | 2021 | |
| Zyla Life Sciences, INC. | $27.91 | 2019-2020 | |
| Grt US Holding, INC. | $27.35 | 2022 | |
| Abbott Laboratories | $23.44 | 2021 | |
| Bioventus LLC | $23.03 | 2023 | Exogen Ultrasound Bone Healing System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $20.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Buro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.